USRD Fees and Costs — Themes US R&D Champions ETF

Data updated: 2026-08-24

The net expense ratio is 0.29%. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $53 in broker commissions, 0.0065% of average net assets, and portfolio turnover was 56%.

USRD Fees and Expenses

Annual operating expenses and sales charges of USRD. Prospectus, as of January 31, 2026.

Annual operating expenses
Management fee0.29%
12b-1 fee0.00%
Other expenses0.00%
Gross expense ratio0.29%
Fee waiver—
Net expense ratio0.29%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

USRD Costs Over Time

On $10,000 invested in USRD, assuming 5% a year before costs, total costs come to $188 over 5 years, cutting the return by 0.31% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.29%)$30$96$167
Trading costs (broker commissions)$1$2$4
Lost growth on money paid in costs$0$5$17
Total costs$31$103$188
Value after costs$10,469$11,474$12,575
Impact on return, per year0.31%0.31%0.31%

USRD Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.

  • Explicit cost rate (commissions ÷ average net assets): 0.0065%
  • Total broker commissions: $53
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 56%
  • Securities lending: none during the year

USRD Agency Brokers

Commissions paid.

BrokerAmountShare
OLD MISSION MARKETS LLC$3871.70%
GOLDMAN SACHS & CO. LLC$1528.30%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.